Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Amir Nashat

Affiliations

  • Director at Morphic Holding Inc. (MORF), 2019-07-01
  • Director at Selecta Biosciences Inc (SELB), 2019-06-18
  • Director at Syros Pharmaceuticals Inc. (SYRS), 2019-06-12
  • Large Shareholder, Director at Scholar Rock Holding Corp (SRRK), 2019-05-24
  • Director at Fate Therapeutics Inc (FATE), 2019-05-07
  • Director at Atyr Pharma Inc (LIFE), 2018-05-17
  • Director at Bind Therapeutics Inc (BIND), 2015-06-10
  • Director at Receptos Inc. (RCPT), 2014-06-06
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
MORF $15.00 8,173 Director 151,879 2019-07-01 Filing
MORF $15.00 116,827 Director 2,171,067 2019-07-01 Filing
SELB $1.50 1,125,756 Director 2,676,234 2019-01-25 Filing
SELB $1.50 11,258 Director 26,760 2019-01-25 Filing
SELB $1.50 7,711 Director 18,329 2019-01-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FATE $14.16 463 Director 1,473,186 2019-01-30 Filing
FATE $14.16 340 Director 1,473,649 2019-01-30 Filing
FATE $14.16 990 Director 1,473,989 2019-01-30 Filing
FATE $14.16 51,224 Director 1,474,979 2019-01-30 Filing
FATE $14.16 941 Director 1,526,203 2019-01-29 Filing